Recovery of erectile function in patients after radical prostatectomy using platelet rich plasma and extracorporeal shock wave therapy: a controlled study
- 25 February 2026
- journal article
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 25 (3)
Abstract
Background. Prostate cancer (PCa) remains one of the leading oncological causes of morbidity in men. Despite advances in modern surgical techniques, including nerve-sparing radical prostatectomy (RP), erectile dysfunction (ED) remains a frequent and significant complication that substantially affects patients’ quality of life. Currently available rehabilitation methods have limitations in terms of effectiveness or accessibility. Aim. To evaluate the efficacy and safety of the combined use of autologous plasma enriched with platelet-rich plasma (PRP) and extracorporeal shockwave therapy (ESWT) in the restoration of erectile function in patients with erectile dysfunction following nerve-sparing radical prostatectomy. Materials and Methods. A prospective controlled study included 46 patients who had undergone unilateral or bilateral nerve-sparing robot-assisted RP. Group 1 received PRP injections combined with ESWT sessions. Group 2 (control) received tadalafil therapy. Assessments were conducted at baseline and on the 60th day of treatment. Validated scales were used: IIEF-5, SEP, EHS, IPSS, QOL, ICIQ-SF, GAQ, as well as penile vascular pharmacodopplerography (PDG), uroflowmetry (UFM), and total testosterone levels. Results. The combination therapy group (PRP + ESWT) demonstrated a significant improvement in erectile function indicators: IIEF-5 (p < 0.001), SEP (p < 0.001), EHS (p < 0.001), improved hemodynamics according to PDG (PSV and RI, p < 0.001), resolution of urinary incontinence symptoms per ICIQ-SF (p < 0.001), and improved urination according to UFM data (p < 0.001). No significant improvement in erectile function was recorded in the control group. No differences in safety profiles were observed between the groups. Conclusion. The combination of PRP and ESWT showed high clinical efficacy and safety in patients with postprostatectomy erectile dysfunction. This method warrants further investigation and may be recommended as an effective penile rehabilitation strategy following RP.Keywords
This publication has 33 references indexed in Scilit:
- Prostatectomy postoperative urinary incontinence: From origin to treatmentPrecision Medical Sciences, 2023
- Dual effect of chitosan activated platelet rich plasma (cPRP) improved erectile function after cavernous nerve injuryJournal of the Formosan Medical Association, 2022
- Changes in quality of life and lower urinary tract symptoms over time in cancer patients after a total prostatectomy: systematic review and meta-analysisSupportive Care in Cancer, 2021
- Early Clinical Results of the Tolerability, Safety, and Efficacy of Autologous Platelet-Rich Plasma Administration in Erectile DysfunctionSexual Medicine, 2021
- Two phase I/II clinical trials for the treatment of urinary incontinence with autologous mesenchymal stem cellsStem Cells Translational Medicine, 2020
- What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini reviewHeliyon, 2020
- 146 The Efficacy of Platelet-Rich Plasma (PRP) as a Supplemental Therapy for the Treatment of Erectile Dysfunction (ED): Initial OutcomesThe Journal of Sexual Medicine, 2017
- Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat modelJournal of Tissue Engineering and Regenerative Medicine, 2013
- Technical Refinement and Learning Curve for Attenuating Neurapraxia During Robotic-Assisted Radical Prostatectomy to Improve Sexual FunctionEuropean Urology, 2012
- Microenvironmental Control of the Breast Cancer Cell CycleThe Anatomical Record, 2012